Embryonic Stem Cell Research Foe, Tracy Deisher, CEO of Ave Maria Biotechnology, Seeks to Market Pro-Life Vaccines

Published: Oct 04, 2010

Xconomy -- The woman who helped bring the U.S. embryonic stem cell research enterprise to a standstill for a couple weeks this summer is also a Seattle biotech entrepreneur who wants to create what she calls the first pro-life vaccine company.

Back to news